Official Title
Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)
Brief Summary

This is an expanded access program (EAP) for eligible participants designed to provideaccess to autologous muscle derived cells (AMDCs). Treating physicians may submitrequests for expanded access to Cook MyoSite's investigational product by email toMYO-ExpandedAccess@CookMyoSite.com.

Detailed Description

Cook MyoSite, Inc. (Cook MyoSite) is committed to conducting rigorous, controlled
clinical trials with variable inclusion and exclusion criteria based upon the indicated
use under investigation. Participation in our clinical trials is the first and most
preferable route to access our investigational product.

We understand that there may be patients with a serious, life-threatening disease or
condition that have explored all other treatment options and are unable or ineligible to
participate in our clinical trials. Expanded access, otherwise known as "compassionate
use" or "pre-approval access," is a potential pathway to access an investigational
product that a patient may otherwise be unable to receive.

Cook MyoSite will consider providing an investigational product to a qualified requesting
physician currently licensed within the United States via the United States Food and Drug
Administration's (FDA's) expanded access pathway outside of an active clinical trial when
eligibility criteria are met.

Available
Individual Patients

Biological: Autologous Muscle Derived Cells (AMDCs)

Eligibility Criteria

Eligibility Criteria:

1. The patient has a serious or life-threatening disease or condition with no
satisfactory alternative.

2. Positive assessment that the anticipated benefits outweigh the risks to the patient.

3. Positive assessment that Cook MyoSite has an adequate supply of resources for
producing the investigational product.

4. A determination that expanded access will not interfere with Cook MyoSite's ability
to complete clinical trials in a timely fashion or which might otherwise delay
marketing approval and ultimately availability to all patients.

5. The patient can undergo a muscle biopsy procedure(s).

6. The patient can undergo Cook MyoSite's required donor screening and testing.

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
United States
Locations

Cook MyoSite, Inc.
Pittsburgh, Pennsylvania, United States

Contacts

Cook MyoSite
412-963-7380
MYO-ExpandedAccess@CookMyoSite.com

NCT Number